ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,761, issued on Feb. 24, was assigned to PREMAS BIOTECH PVT LTD (Gurgaon, India).

"Recombinant expression platform, constructs and methods for expression of difficult to express proteins (DTE-PS)" was invented by Kajal Arora (Gurgaon, India), Prabuddha Kumar Kundu (Gurgaon, India), Ruchir Rastogi (Gurgaon, India) and Nupur Mehrotra Arora (Gurgaon, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to expression of SARS-CoV like virus proteins [S, M and E] proteins; recombinant polynucleotides, polypeptides; constructs, virus-like particles (VLPs); immunogenic compositions or vaccines comprising Virus Like Particles (VL...